MaDD, or Maladaptive Daydreaming Disorder, is a mental health condition where a person daydreams so excessively and vividly that it interferes with daily life. People with MaDD don’t just zone out for a few minutes. They can spend four or more hours a day lost in elaborate, immersive fantasy worlds, often struggling to stop even when they want to. The condition is not yet listed in any major diagnostic manual, but a growing body of research supports recognizing it as a distinct disorder, and hundreds of thousands of people worldwide identify with it and seek support in online communities.
How MaDD Differs From Normal Daydreaming
Everyone daydreams. The difference with MaDD is scale, intensity, and control. Normal daydreaming is brief and easy to snap out of. MaDD daydreams are extraordinarily vivid and detailed, with complex characters, storylines, and emotional arcs that can continue for weeks or months like an internal television series. People with the condition often describe “losing themselves” in these fantasies, disconnecting from the world around them in a way that resembles dissociation.
The word “maladaptive” is key. It means the daydreaming has become an unhealthy coping mechanism, typically developing as a way to manage anxiety, depression, loneliness, or a history of trauma. What may start as a comforting escape in childhood gradually takes on a compulsive quality. People with MaDD frequently report wanting to stop or cut back but finding it very difficult, similar to the pull of an addiction. In one study, participants spent an average of just over four hours per day daydreaming, with some reporting as many as 15 hours. Research has found that people with MaDD spend roughly 56% of their waking hours in fantasy.
Recognizable Signs and Behaviors
MaDD has a distinctive set of symptoms that go beyond just “spacing out.” The most common include:
- Extremely long daydreaming episodes that can last hours, often feeling difficult to interrupt or end voluntarily
- Repetitive physical movements during daydreaming, such as pacing back and forth, rocking, swinging, hair twisting, or flipping a pen
- Facial expressions or whispering that match the emotional content of the daydream
- Strong emotional reactions to events happening inside the daydream, including laughing, crying, or feeling intense excitement
- Difficulty completing tasks at work or school because the urge to return to a daydream is overwhelming
- Distress or frustration about the amount of time spent daydreaming
The physical movements are a particularly telling feature. Researchers describe them as repetitive, coordinated, and rhythmic, similar to what clinicians call motor stereotypies. These movements appear to amplify the immersive quality of the daydream, possibly by enhancing focus through a self-hypnotic effect, much like the swinging of a pendulum. For many people, the movement feels essential. One person described it this way: “Daydreaming is more intense but also much more pleasant while I am in motion. Sometimes I want to jump out of my skin when I daydream and sit in a chair.”
Music and Other Common Triggers
Music is one of the most frequently reported triggers. Many people with MaDD describe specific songs or playlists that reliably launch them into a daydream, often matching the emotional tone of whatever storyline they’re immersed in. In documented cases, individuals report that music is “mandatory” for their daydreaming to work, or that getting their first MP3 player as a child was the moment their daydreaming escalated. Other common triggers include being in motion (walking, running, riding a train), boredom, stress, and exposure to movies, books, or TV shows that feed into existing fantasy narratives.
The combination of music and movement together creates a particularly powerful loop. A person might put on headphones, begin pacing a familiar path in their room, and slip into a daydream that lasts for hours. Understanding your personal triggers is one of the first practical steps in managing the condition.
The Real-World Impact
MaDD can significantly disrupt a person’s ability to function. The hours lost to daydreaming directly eat into time for work, studying, socializing, and basic responsibilities. In one 14-day study tracking people with MaDD, almost half were unemployed, and over a quarter had attempted suicide at least once. Daily spikes in maladaptive daydreaming were associated with increases in same-day psychological symptoms, suggesting the condition and mental health distress feed each other in a cycle.
Many people with MaDD describe a painful contradiction: the daydreams themselves feel pleasurable and emotionally rich, but the aftermath brings guilt, shame, and frustration over lost time. Relationships suffer because the person may prefer retreating into fantasy over engaging with real people. Academic and career goals stall. The gap between a person’s vivid inner life and their actual circumstances can become a source of deep unhappiness.
Overlap With ADHD, OCD, and Other Conditions
MaDD rarely shows up alone. In one study that conducted full psychiatric assessments, nearly 77% of people with MaDD also met the diagnostic criteria for ADHD, with the vast majority showing the inattentive subtype specifically. This makes sense on the surface: both conditions involve difficulty controlling where your attention goes. However, researchers have argued that the mechanism is different. ADHD inattention is a failure to sustain focus on external tasks, while MaDD involves intense, sustained focus directed inward. The daydreamer isn’t unable to concentrate. They’re concentrating deeply on something no one else can see.
Depression and generalized anxiety are also common, reported by roughly 41% and 33% of people with MaDD in one sample. About 10% reported obsessive-compulsive disorder, and 14% reported social anxiety. These conditions may contribute to MaDD by creating the emotional pain that daydreaming serves to escape, or they may be worsened by the isolation and lost productivity that MaDD causes. Likely, it works in both directions.
Why It’s Not in Diagnostic Manuals Yet
MaDD is not currently recognized in the DSM-5-TR or the ICD-11, the two major systems used to classify mental health conditions worldwide. This doesn’t mean it isn’t real. It means the formal process of inclusion requires additional evidence, particularly long-term studies tracking the condition over time and more data on how it responds to treatment. The concept was first described by Israeli psychologist Eli Somer in 2002, and research has accelerated significantly in the past decade. Meta-analyses have concluded that MaDD cannot be fully explained by any existing diagnosis, supporting its status as a distinct condition.
The practical consequence of this gap is that many people struggle to get their experience taken seriously by clinicians who may not be familiar with the research. If you recognize yourself in these descriptions, knowing the term “maladaptive daydreaming” and being able to point to published research can help bridge that conversation.
Treatment Approaches
Because MaDD isn’t formally classified, there’s no standardized treatment protocol. But the approaches that have been studied show real promise. Cognitive behavioral therapy (CBT) adapted for MaDD has been the most documented approach. In one published case, a 15-week CBT program built around four phases (coping skills, behavior modification, cognitive restructuring, and relapse prevention) reduced a patient’s score on the Maladaptive Daydreaming Scale from 66 to 32, dropping it well below the clinical threshold of 40.
The therapeutic strategy typically involves identifying the emotional needs the daydreaming fulfills, developing healthier ways to meet those needs, and gradually building awareness of triggers so you can interrupt the cycle before it takes hold. Mindfulness practices can help strengthen the ability to notice when a daydream is pulling you in and redirect attention to the present moment. For people whose MaDD is connected to trauma, therapy that addresses the underlying traumatic experiences may reduce the need for dissociative escape.
Some individuals have responded to medication, particularly drugs that target obsessive-compulsive symptoms. One long-term case documented over a decade showed favorable results with medication that helped the patient feel more control over the urge to daydream. However, medication research for MaDD is still very limited, mostly consisting of individual case reports rather than controlled trials.
Screening and Self-Assessment
The most widely used tool for identifying MaDD is the Maladaptive Daydreaming Scale (MDS-16), a 16-item self-report questionnaire. Each item is rated on a scale from 0% to 100%, and the questions cover how much time you spend daydreaming, how much control you feel you have over it, how distressing it is, and how much it interferes with your responsibilities and relationships. A score of 35 or above (corresponding to the 60th percentile) has been shown to reliably distinguish excessive daydreamers from typical ones. The scale is freely available online and can be a useful starting point before seeking professional help.